本頁面由Tiger Trade Technology Pte. Ltd.提供服務

IDEAYA Biosciences

37.73
+0.07000.19%
盤後37.990.2600+0.69%19:30 EDT
成交量:63.99萬
成交額:2,413.03萬
市值:36.32億
市盈率:-19.29
高:38.46
開:37.71
低:37.24
收:37.66
52周最高:42.68
52周最低:24.28
股本:9,627.48萬
流通股本:9,437.45萬
量比:1.21
換手率:0.68%
股息:- -
股息率:- -
每股收益(TTM):-1.9561
每股收益(LYR):-1.2849
淨資產收益率:-16.22%
總資產收益率:-11.54%
市淨率:3.03
市盈率(LYR):-29.36

資料載入中...

2022/03/18

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/17

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/15

重要事件披露

8-K - Current report
2022/02/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/01

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/15

重要事件披露

8-K - Current report
2021/11/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/11

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/10

重要事件披露

8-K - Current report
2021/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/12

重要事件披露

8-K - Current report
2021/06/28

重要事件披露

8-K - Current report
2021/06/14

重要事件披露

8-K - Current report
2021/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report